June 15, 2020 / 8:52 AM / in 18 days

BRIEF-Zealand Pharma: Results On Use Of Regular Human Insulin Delivered By V-Go In Older Adults With Type 2 Diabetes

June 15 (Reuters) - Zealand Pharma A/S:

* SAID ON SATURDAY IT HAD PRESENTED ELABORATED RESULTS ON THE USE OF REGULAR HUMAN INSULIN DELIVERED BY V-GO IN OLDER ADULTS WITH TYPE 2 DIABETES

* IN OLDER ADULTS WITH TYPE 2 DIABETES, USE OF HUMAN REGULAR INSULIN DELIVERED BY V-GO DEMONSTRATED SIMILAR GLYCEMIC CONTROL WITH NO INCREASED HYPOGLYCEMIA RISK COMPARED TO USE OF RAPID ACTING INSULIN ANALOGS

* THE USE OF U-100 REGULAR HUMAN INSULIN WITH V-GO WEARABLE INSULIN DELIVERY DEVICE HAS NOT YET BEEN CLEARED BY THE FOOD AND DRUG ADMINISTRATION OR EUROPEAN UNION

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below